Assessing GPT‐4's accuracy in answering clinical pharmacological questions on pain therapy

GPT-4 demonstrates potential as a tool for delivering medical information, particularly in pain management. However, limitations such as incomplete pharmacological data and the potential for contextual carryover in follow-up questions suggest that further refinement is necessary. Developing specialized artificial intelligence tools that integrate real-time pharmacological databases could improve accuracy and reliability for clinical decision-making.